DCD App vs KAK

Unlock the complexities of Donation After Cardiac Death (DCD) certification with our user-friendly companion app. Designed to assist healthcare professionals, this app offers step-by-step guidance alongside demonstration videos for mastering DCD testing and certification procedures. Key Features: Step-by-Step Guidance: Seamlessly navigate the DCD certification process with our comprehensive, easy-to-follow instructions tailored to Indian healthcare standards. Handy Reference Materials: Access a curated collection of reference materials, guidelines, and protocols essential for DCD certification in India, all at your fingertips. Interactive Checklist: Stay organized and ensure no step is overlooked using our interactive checklist tool, designed to keep your certification process on track. Offline Accessibility: Enjoy uninterrupted access to app features, even without an internet connection, ensuring assistance is available whenever and wherever it's needed. Intuitive Interface: Navigate effortlessly through the app's user-friendly interface, designed for simplicity and ease of use during the certification journey. Timely Updates: Stay informed about the latest developments, regulatory updates, and advancements in DCD certification through timely notifications and alerts.

Quick risk-calculator for contrast-induced nephropathy based on validated clinical model KAK-CIN Score is a clinical decision-support tool designed to help healthcare professionals estimate the probability of Contrast-Induced Nephropathy (CIN) in patients who will receive intravascular contrast medium. The algorithm is based on the peer-reviewed study by Kulkarni et al (Indian Journal of Nephrology, 2023) which derived and validated a simplified risk score system. Key features: Input four key patient variables: Estimated Glomerular Filtration Rate (eGFR) Contrast volume (mL) Route of contrast administration (arterial vs intravenous) Presence or absence of Diabetes Mellitus Instantly calculates a risk-percentage for CIN and provides a risk category (e.g., low, moderate, high) and provides the CIN Score. Published Journal: https://indianjnephrol.org/?view-pdf=1&embedded=true&article=af81b65b1e790875fb17d4a368ca9457Aplh7GbponE%3D Why use KAK-CIN Score? The original study included 1,300 patients (derivation 1,000 + validation 300) with an observed incidence of CIN of 3.8 %. The model showed high sensitivity (90.4 %) and specificity (98.8 %) in the validation cohort. Unlike many prior CIN risk models that were limited to cardiac catheterisation, this score covers both intra-arterial and intravenous contrast exposure. Important disclaimer This app is for educational and decision-support purposes only. It does not replace clinical judgement, institutional protocols or specialist consultation. Use results in conjunction with the full clinical context. The authors are not responsible for any clinical outcomes resulting from use of this tool. Always follow local guidelines. Privacy & Security No patient-identifiable data is stored beyond your device.